Publications
Statement by Alliance for Aging Research Senior Director Debbie Zeldow before the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committe Meeting, concerning Eli Lilly and Company's bone formation drug, Forteo
| Type: | Testimony |
| Date: | July 27, 2001 |
| Related Topics: | Drug Development, Health, Osteoporosis |
My name is Deborah Zeldow, and I am the Senior Director of the Alliance for Aging Research. Thank you for the opportunity to come before this committee today to address the promising findings of Forteo™ (teriparatide, Lilly), Eli Lilly and Company's bone formation drug.